Analysts' Actions: LLL, MAR, NFLX, JNPR, EOG

NEW YORK ( TheStreet) -- CHANGE IN RATINGS

Allegiant Travel ( ALGT) downgraded at Deutsche from Buy to Hold, Deutsche Bank said. $54 price target.

Alaska Air ( ALK) downgraded at Deutsche from Buy to Hold, Deutsche Bank said. $80 price target.

Apache ( APA)upgraded to buy at TheStreet Ratings.

Acuity Brands ( AYI) downgraded at from Buy to Hold. Valuation call, as the stock is up 46% over the past three months.

Brown & Brown ( BRO) rated new Buy at Deutsche. $27 price target. Company could resume organic growth in 2012.

Choice Hotels ( CHH) downgraded at Credit Suisse from Neutral to Underperform, Credit Suisse said. $32 price target. Estimates also cut, on weaker unit growth.

EOG Resources ( EOG) upgraded at Deutsche from Hold to Buy, Deutsche Bank said. $125 price target. Company is seeing strong production trends.

Hyatt Hotels ( H) upgraded at BofA/Merrill to buy, Bank of America/Merrill Lynch said. Company has a strong balance sheet and minimal exposure to Europe. $50 price target.

Starwood Hotels ( HOT) downgraded at BofA/Merrill to Neutral, Bank of America/Merrill Lynch said. $60 price target. Growth is slowing in Asia and Europe.

Juniper ( JNPR) upgraded at Piper from Neutral to Overweight, Piper Jaffray said. $25 price target. Valuation call, as new product cycles should eventually drive growth.

L-3 Communications ( LLL) upgraded at Deutsche from Hold to Buy, Deutsche Bank said. Valuation call, based on a $77 price target.

Marriott ( MAR) upgraded at BofA/Merrill to Buy, Bank of America/Merrill Lynch said. Company can meet or exceed new, lower expectations. $40 price target.

Netflix ( NFLX) downgraded at BofA/Merrill from Neutral to Underperform, Bank of America/Merrill Lynch said. $85 price target. Valuation call, as the stock has gained 42% year-to-date.

NVR ( NVR) downgraded at JP Morgan from Overweight to Neutral, JP Morgan said. $770 price target. Company will likely repurchase fewer shares.

Precision Drilling ( PDS) rated new Buy at Dahlman. $14 price target. Company is leveraged to higher demand for horizontal drilling.

Penn National ( PENN) upgraded at BofA/Merrill from Neutral to Buy, Bank of America/Merrill Lynch said. $48 price target. New locations in Ohio should drive growth.

Regeneron ( REGN) upgraded at Baird from Neutral to Outperform, Robert Baird said. $81 price target. Eylea is growing faster than expected.

Stericycle ( SRCL) upgraded at JP Morgan from Neutral to Overweight, JP Morgan said. $94.50 price target. Company offers growth at an attractive price.

Tractor Supply ( TSCO) upgraded at Goldman from Sell to Neutral, Goldman Sachs said. Margin growth should begin to accelerate. $72 price target.

STOCK COMMENTS / EPS CHANGES

Alcoa ( AA) estimates, target reduced at JP Morgan. AA estimates were cut through 2012, JP Morgan said. Aluminum prices remain weak and the company continues to face higher costs. Overweight rating and new $13 price target.

Alcoa numbers adjusted at UBS. Shares of AA now seen reaching $10.25, according to UBS. Estimates lowered on lower LME prices and ongoing European weakness. Neutral rating.

Acuity Brands ( AYI) numbers increased at JMP. AYI estimates were raised through 2012, JMP Securities said. Higher pricing should drive margin expansion. Outperform rating and new $64 price target.

Acuity Brands numbers raised at Jefferies. Shares of AYI now seen reaching AYI, Jefferies said. Estimates also raised on solid first quarter results. Hold rating.

Celgene ( CELG) target raised at Citigroup. CELG price target increased to $80, according to Citigroup. Company released positive guidance. Buy rating.

Celgene numbers raised at Jefferies. Shares of CELG now seen reaching $78, Jefferies said. Estimates also raised on bullish 2012 guidance. Buy rating.

Capital One ( COF) added to Top Pick List at FBR. COF was placed on the Top Pick list, FBR Capital Markets said. Recent acquisitions should boost future earnings.

Cirrus Logic ( CRUS) estimates raised at Oppenheimer through 2012, Oppenheimer said. Positive guidance update. Perform rating.

CVS Caremark ( CVS) numbers raised at Credit Suisse. Shares of CVS now seen reaching $48, according to Credit Suisse. Estimates also increased, as the company has several potential earnings tailwinds. Outperform rating.

Juniper ( JNPR) estimates lowered at Oppenheimer through 2012, Oppenheimer said. Disappointing negative pre-announcement. Perform rating.

Juniper estimates, target lowered at Goldman. JNPR estimates were cut through 2013, Goldman Sachs said. Carriers are spending less and the company appears to be losing market share in the router business. Neutral rating and new $19 price target.

Juniper Networks estimates lowered at UBS. JNPR estimates lowered through 2012, UBS said. Weaker than expected preliminary 4Q results. Neutral rating.

Juniper estimates lowered at Jefferies. JNPR estimates lowered through 2012, Jefferies said. Negative pre-announcement. Buy rating.

Southwest ( LUV) estimates lowered at UBS. LUV estimates lowered through 2012 on December revenue, UBS said. Maintain $9.50 price target and Neutral rating.

Macy's ( M) estimates, target boosted at Credit Suisse. Shares of M now seen reaching $36, according to Credit Suisse. Estimates also upped, given strong sales momentum. Outperform rating.

Regeneron Pharmaceuticals ( REGN) price target raised at Citigroup. REGN price target increased to $68 on strong initial Eylea sales, Citigroup said. Neutral rating.

Schnitzer Steel ( SCHN) numbers cut at Goldman. Shares of SCHN now seen reaching $47, according to Goldman Sachs. Estimates also reduced, given margin compression. Neutral rating.

>To submit a news tip, email: tips@thestreet.com.

RELATED STORIES:


Follow TheStreet on Twitter and become a fan on Facebook.
This article was written by a staff member of RealMoney.com.